Friday, July 15, 2016 5:24:05 PM
- August 1, 2016: NDA filed by company (just a guess on the date)
- October 1, 2016: FDA Accepts NDA or issues Refuse-To-File (RTF) letter within 60 days of NDA filing.
- April 1, 2017: If NDA accepted, PDUFA (decision) date is set for 6 months later if Rexista is priority review--I think Rexista is priority review? (10 months later if Rexista is standard review)
- ~March 1, 2017: If FDA needs guidance on the NDA, they will set a date for an Advisory Committee (AdCom) 2-4 weeks before the PDUFA date, and publicly release Briefing Docs (BDs) ~3-5 days before the AdCom.
NDA = New Drug Application
PDUFA = Prescription Drug User Fee Act
Recent IPCI News
- Suspension de la négociation par l'Organisme canadien de réglementation des investissements - IPCI • PR Newswire (Canada) • 03/06/2024 12:55:00 PM
- Canadian Investment Regulatory Organization Trading Halt - IPCI • PR Newswire (Canada) • 03/06/2024 12:51:00 PM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM